Antithrombotic therapy with intracoronary stenting

Heart

Volumn 78, Issue SUPPL.2, 1997, Pages 21-23

  Steinhubl, Steven R ^a   Lincoff, A Michael ^a,b  

^a JACOBS ENGINEERING   (United States)

^b Department of Cardiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; DIPYRIDAMOLE; HEPARIN; PHENPROCOUMON; TICLOPIDINE; WARFARIN;

ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030663387     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.Suppl_2.21     Document Type: Article

References (10)

1. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324:13-17.
2. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz- Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-61.
3. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
4. Parsson H, Cwikiel W, Johansson K, Swartbol P, Norgren L. Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and Wallstent placement compared with angioplasty alone. Cardiovasc Intervent Radiol 1994;17:190-6.
5. Gawaz M, Neumann F-J, Ott I, May A, Rudiger S, Schomig A. Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. Heart 1996;76:166-72.
6. Gawaz M, Neumann F-J, Ott I, May A, Schomig A. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation 1996;94: 279-85.
7. Neumann F-J, Gawaz M, Ott I, May A, Mossmer G, Schomig A. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz- Schatz stenting. J Am Coll Cardiol 1996;27:15-21.
8. Schomig A, Neumann F-J, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
9. Zidar JP, Kruse KR, Thel MC, Kereiakes D, Muhlestein JB, Davidson CJ, et al. Integrelin for emergency coronary artery stenting. J Am Coll Cardiol 1996;27:138A.
10. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent II pilot study. Circulation 1996;93:412-22.